Diltiazem Hci 51662-1335-02
- Manufacturer
- Hf Acquisition Co Llc, Dba Healthfirst
- Dosage Form
- Injection
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- December 21, 2018
- Listing Expires
- December 31, 2026
- Application
- ANDA078538
Need to source Diltiazem Hci? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Diltiazem Hydrochloride | 5 mg/mL |
Drug Class
Calcium Channel Antagonists [MoA]Calcium Channel Blocker [EPC]
Selected Package
51662-1335-02Selected1 VIAL in 1 POUCH (51662-1335-2) / 5 mL in 1 VIAL
Other packages for this product(1)
5 mL in 1 VIAL (51662-1335-1)